Direct determination of lead in blood by electrothermal atomic absorption spectrometry with L'vov platform and matrix modification

An electrothermal atomic-absorption procedure with the L'vov platform and a simple five- or ten-fold sample dilution with a matrix-modifier solution containing diammonium hydrogenphosphate, Triton X-100 and nitric acid, is described for the direct determination of relatively low levels of lead in heparinized blood. The graphite-furnace parameters and matrix-modifier composition are optimized. Sensitivity, imprecision, accuracy and detection limit are reported. Results obtained by standard addition for ten human blood samples (30–400 μg l^?1 lead) were confirmed by an extraction/flame atomic-absorption reference method. Differences in mean lead values ranged from 2 to 31 μg l^?1 with 5.1% mean relative difference. The mean relative standard deviations for consecutive and between-day determinations were 4.6 and 9%, respectively. Accuracy was verified by analyzing six bovine-blood standards certified for lead in the range 70–1100 μg l^?1; deviations of found concentrations from expected values ranged from 0 to 44 μg l^?1 with 4.3% mean relative error. Recovery experiments done with human blood gave 104% (90–121%) of the added lead. The method offers several advantages for routine application in comparison with the extraction/flame atomic-absorption procedure.